Herbal treatment for renal diseases

Area of Science:

• Nephrology
• Pharmacology
• Integrative Medicine

Background:

• Renal fibrosis is a common outcome of chronic kidney diseases (CKD).
• Current Western medicine treatments for CKD include dietary protein restriction, blood pressure control, and specific drug classes.
• The renoprotective effects of traditional Chinese herbal medicine (TCM) are not well-established.

Purpose of the Study:

• To review recent research on the pharmacological interventions of progressive renal diseases using Chinese herbs.
• To explore the potential benefits and risks of specific TCMs in managing kidney-related injuries.

Main Methods:

• Literature review of studies investigating Chinese herbal medicine for renal diseases.
• Analysis of evidence regarding the efficacy and mechanisms of action of selected herbs.
• Discussion of potential adverse effects associated with TCM use in renal patients.

Main Results:

• Certain Chinese herbs, such as Astragalus and a combination including Angelica, Ligusticum, Triptolide, and Rhubarb, may slow CKD progression.
• These herbs demonstrate multi-targeted effects, including reducing proteinuria, improving dyslipidemia, and exhibiting anti-inflammatory properties.
• Mechanisms involve inhibiting TGF-beta overproduction and do not appear to significantly alter systemic blood pressure.

Conclusions:

• Some Chinese herbal medicines offer potential renoprotective benefits for progressive renal diseases.
• Their multi-functional mechanisms, including anti-inflammation and TGF-beta inhibition, are key to their efficacy.
• Caution is advised as certain Chinese herbs may pose risks to patients with kidney diseases.